Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
207,440,936
-
Total 13F shares
-
20,583,732
-
Share change
-
+2,896,358
-
Total reported value
-
$952,626,441
-
Put/Call ratio
-
381%
-
Price per share
-
$46.28
-
Number of holders
-
125
-
Value change
-
+$139,786,313
-
Number of buys
-
59
-
Number of sells
-
60
Institutional Holders of Esperion Therapeutics, Inc. - Common Stock, par value $0.001 per share (ESPR) as of Q2 2017
As of 30 Jun 2017 Esperion Therapeutics, Inc. - Common Stock, par value $0.001 per share (ESPR) had 125 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 20,583,732 shares of stock of the company.
Largest 10 holders included Pentwater Capital Management LP, BB BIOTECH AG, STATE STREET CORP, FMR LLC, BlackRock Inc., CREDIT SUISSE AG/, Boxer Capital, LLC, DISCOVERY CAPITAL MANAGEMENT, LLC / CT, Aisling Capital LLC, and VANGUARD GROUP INC.
This table shows 126 institutional shareholders of the security as of 30 Jun 2017.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.